Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.

Molecular Cell
Changmin PengHuadong Pei

Abstract

The Hippo pathway is crucial in organ size control and tissue homeostasis, with deregulation leading to cancer. An extracellular nutrition signal, such as glucose, regulates the Hippo pathway activation. However, the mechanisms are still not clear. Here, we found that the Hippo pathway is directly regulated by the hexosamine biosynthesis pathway (HBP) in response to metabolic nutrients. Mechanistically, the core component of Hippo pathway (YAP) is O-GlcNAcylated by O-GlcNAc transferase (OGT) at serine 109. YAP O-GlcNAcylation disrupts its interaction with upstream kinase LATS1, prevents its phosphorylation, and activates its transcriptional activity. And this activation is not dependent on AMPK. We also identified OGT as a YAP-regulated gene that forms a feedback loop. Finally, we confirmed that glucose-induced YAP O-GlcNAcylation and activation promoted tumorigenesis. Together, our data establish a molecular mechanism and functional significance of the HBP in directly linking extracellular glucose signal to the Hippo-YAP pathway and tumorigenesis.

Associated Datasets

Nov 23, 2017·Changmin Peng

References

Aug 1, 2002·Proceedings of the National Academy of Sciences of the United States of America·Senitiroh Hakomori
Mar 3, 2004·Glycoconjugate Journal·Masaya Ono, Senitiroh Hakomori
Jun 3, 2005·Nature Reviews. Drug Discovery·Danielle H Dube, Carolyn R Bertozzi
Dec 1, 2005·Science's STKE : Signal Transduction Knowledge Environment·Dona C Love, John A Hanover
Apr 18, 2007·Genes & Development·Duojia Pan
Nov 6, 2007·Current Biology : CB·Fernando D CamargoThijn R Brummelkamp
Dec 26, 2007·The Journal of Biological Chemistry·Yawei HaoXiaolong Yang
May 13, 2008·Molecular Cell·D Grahame Hardie
Sep 30, 2008·Current Opinion in Structural Biology·Ramon Hurtado-GuerreroDaan M F van Aalten
Mar 21, 2009·Nature Protocols·Paul J BoersemaAlbert J R Heck
Apr 1, 2010·Journal of Clinical Pathology·Celso A ReisLeonor David
Apr 17, 2010·Current Signal Transduction Therapy·Tracey M Gloster, David J Vocadlo
Apr 24, 2010·Developmental Cell·Xaralabos VarelasLiliana Attisano
May 5, 2010·Genes & Development·Bin ZhaoKun-Liang Guan
May 15, 2010·Trends in Biochemical Sciences·C SlawsonG W Hart
Jul 14, 2010·Current Biology : CB·Felix A GruscheKieran F Harvey
Oct 19, 2010·Developmental Cell·Duojia Pan
Nov 26, 2010·British Journal of Cancer·J AvruchN Bardeesy
Dec 9, 2010·Development·Georg Halder, Randy L Johnson
Mar 19, 2011·Molecular Biology and Evolution·Dror Hilman, Uri Gat
May 11, 2011·The EMBO Journal·Leticia Sansores-GarciaGeorg Halder
Jun 10, 2011·Nature·Sirio DupontStefano Piccolo
Aug 13, 2011·Development·Ken-Ichi WadaHiroshi Sasaki
Dec 20, 2011·Biochimica Et Biophysica Acta·Barbara AdamczykPauline M Rudd
Aug 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·John M LamarRichard O Hynes
Aug 17, 2012·Nature Reviews. Molecular Cell Biology·Georg HalderStefano Piccolo
Sep 14, 2012·Genes & Development·Jung-Soon MoKun-Liang Guan
Feb 23, 2013·Genes & Development·Fa-Xing Yu, Kun-Liang Guan
Aug 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Mei XinEric N Olson
Aug 22, 2013·Frontiers in Endocrinology·Yann FardiniTarik Issad
Feb 18, 2014·Journal of Cell Science·Barry M Gumbiner, Nam-Gyun Kim
Apr 29, 2014·Cancer Letters·Jay Prakash SinghXiaoyong Yang

❮ Previous
Next ❯

Citations

Sep 6, 2018·Annual Review of Genetics·Jyoti R Misra, Kenneth D Irvine
Dec 21, 2018·FEBS Letters·Bernard A CallusSteve D Wilton
Mar 1, 2019·Molecular Biology of the Cell·Alex C Broussard, Michael Boyce
Jul 13, 2019·Proceedings of the National Academy of Sciences of the United States of America·Veronica M PravataDaan M F van Aalten
Jan 15, 2020·Proceedings of the National Academy of Sciences of the United States of America·Kenneth Kin Lam WongEsther M Verheyen
Apr 10, 2020·The Journal of Experimental Medicine·Liwei AnZhaocai Zhou
Jun 3, 2020·The Journal of Experimental Medicine·Kevin P MengManish J Butte
Feb 26, 2020·The Journal of Biological Chemistry·Villo MuhaDaan M F van Aalten
Apr 13, 2018·Cancers·Janine S A WarrenJohn M Lamar
Aug 21, 2020·EMBO Reports·Kenneth Kin Lam Wong, Esther M Verheyen
Apr 1, 2018·Cellular and Molecular Life Sciences : CMLS·Sungho MoonHyun Woo Park
Nov 13, 2018·Signal Transduction and Targeted Therapy·Yi-Ping Wang, Qun-Ying Lei
Dec 20, 2018·Annual Review of Biochemistry·Shenghong MaKun-Liang Guan
May 24, 2020·Acta Biochimica Et Biophysica Sinica·Xiaolei CaoBin Zhao
Jul 1, 2020·Frontiers in Oncology·Hirohito Yamaguchi, Ghina M Taouk
Feb 6, 2018·BMB Reports·Wantae Kim, Eek-Hoon Jho
Sep 5, 2018·Molecular Cancer·Xiaodong ZhangHangyu Li
Nov 11, 2019·Journal of Neuroscience Research·Manas Ranjan Sahu, Amal Chandra Mondal
Oct 2, 2019·Cancers·Liang YanHaoqiang Ying
Oct 1, 2020·Cell Death & Disease·Hyeon Gyu SeoJin Won Cho
Jul 28, 2018·Nature Cell Biology·Antonio TotaroStefano Piccolo
Dec 13, 2019·Wiley Interdisciplinary Reviews. Developmental Biology·Benjamin J van Soldt, Wellington V Cardoso
Sep 19, 2019·Development·John Robert Davis, Nicolas Tapon
Jan 17, 2020·Journal of Experimental & Clinical Cancer Research : CR·Ming QuanJiujie Cui
Jul 6, 2019·BMC Biology·Neha M AkellaMauricio J Reginato
Jun 10, 2020·Proceedings of the National Academy of Sciences of the United States of America·Eunah KimJin Won Cho
Nov 23, 2018·Frontiers in Endocrinology·Qunxiang OngXiaoyong Yang
Jul 10, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhuqing LiWenge Zhu
Jul 16, 2019·Biochimica Et Biophysica Acta. General Subjects·Fangjie YanBo Yang
Sep 29, 2020·Trends in Biochemical Sciences·Francesca ReggianiValentina Sancisi
Nov 27, 2019·JACC. Basic to Translational Science·Shohei IkedaJunichi Sadoshima
Nov 26, 2020·Annual Review of Pathology·Jordan H Driskill, Duojia Pan
Nov 15, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wenxia ZhaoRongguang Shao
Jan 9, 2021·Chemical Reviews·Junfeng MaGerald W Hart
Oct 22, 2020·Cells·Jae Hyung ParkHyun Woo Park
Jan 12, 2021·Developmental Biology·Frank SzulzewskyValeri Vasioukhin
Feb 22, 2021·The Journal of Biological Chemistry·Villő MuhaDaan M F van Aalten
Jul 31, 2020·Physiological Reviews·John C ChathamAdam R Wende

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.